Analyst Neil Doshi from Mizuho Securities reiterated a Buy rating for Electronic Arts Inc. (NASDAQ:EA) with a price target of $84, marking a …
Analyst Sheryl Skolnick of Mizuho Securities marinated a Neutral rating on Tenet Healthcare Corp (NYSE:THC) with a cut price target of $28, marking a …
Analyst Irina Koffler from Mizuho Securities reiterated her Buy rating on Jazz Pharmaceuticals plc (NASDAQ:JAZZ) with a raised price target of $195, marking …
Analyst Abhey Lamba from Mizuho Securites reiterates his Neutral rating on VMware, Inc. (NYSE:VMW) with a raised price target of $61, marking a …
SolarCity Corp In a research report published Friday, Credit Suisse analyst Patrick Jobin downgraded shares of rooftop solar giant SolarCity Corp (NASDAQ:SCTY) from Buy …
TESARO Inc (NASDAQ:TSRO) and Marinus Pharmaceuticals Inc (NASDAQ:MRNS) both made headlines this week as the biotech companies released data on pipeline drugs. While …
In a research report issued Monday, Mizuho analyst Irina Rivkind Koffler downgraded shares of Eagle Pharmaceuticals Inc (NASDAQ:EGRX) from Buy to Neutral, while lowering the …
Marinus Pharmaceuticals Inc Monday turned out to be a nightmare for shareholders of Marinus Pharmaceuticals Inc (NASDAQ:MRNS), as the stock price tumbled 70% following the news …
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Sarepta Therapeutics Inc (NASDAQ:SRPT) are two of this morning’s biggest gainers and losers. One top analyst continues …
In biotech, knowing the competition is integral to understanding how drugs will succeed once they are on the market. Below, analysts weigh in …
